Navigation Links
Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
Date:4/4/2013

ing, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six targeted therapeutic oncology candidates in clinical development. 

Forward-Looking Statement
To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include any statements about Merrimack's strategy, future operations, future financial position and future expectations and plans and prospects for Merrimack, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. In this press release, Merrimack's forward-looking statements include statements about the potential effectiveness of its drug candidates, including the potential benefits of MM-121 in combination with erlotinib, the safety of its drug candidates, the ability to develop a predictive diagnostic and the ability to achieve future clinical success. Such forward-looking statements involve substantial risks and uncertainties that could cause Merrimack's clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the initiation and conduct of future clinical trials, availability of data from ongoing clinical trials, expectations for regulatory approv
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
2. Valeant Pharmaceuticals Provides Update to Recent Event
3. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
4. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
5. European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017
6. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
7. Valeant Pharmaceuticals Announces Private Exchange Offer
8. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
9. Inovio Pharmaceuticals to Present at BioCenturys "Future Leaders in the Biotech Industry" Conference
10. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
11. Pharmaceuticals - Scandinavia Industry Guide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015 Concord Medical Services Holdings Limited ... hospital management solution provider and operator of the largest network ... , today announced it will release its financial results ... on August 17, 2015. Management will hold a ... 8:00 a.m. EDT on August 18, 2015 (8:00 p.m. in ...
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Animal Biotechnology ... offering. This report describes and evaluates ... and pharmaceuticals as well as improvement in food ... the application of biotechnology to manage genetic disorders ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... 10, 2012  - Agreement allows development ... plc (LSE: SHP, NASDAQ: SHPGY ), the ... acquired the rights to develop and market Resolor ® ... agreement  with Janssen Pharmaceutica N.V.  Terms of the agreement ...
... RATON, Fla., Jan. 10, 2012   MX.com today ... Solution designed to help healthcare administrators add new hospital ... by Rush University Medical Center, the program integrates treatment ... 2004, it has grown by 900 percent and demand ...
Cached Medicine Technology:Shire Acquires US Rights to Resolor(R) (prucalopride) 2Shire Acquires US Rights to Resolor(R) (prucalopride) 3Shire Acquires US Rights to Resolor(R) (prucalopride) 4MX.com Launches Pelvic Health Program Model to Help Hospitals Rapidly Expand Key Services 2
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Statement by ... applauds the introduction of the Mental Health Reform Act of 2015 by ... comprehensive mental health reform a reality in America. , “This legislation and ...
(Date:8/4/2015)... Birmingham, OH (PRWEB) , ... August 04, 2015 ... ... announce that it has joined the American Association of Tissue Banks (AATB) as ... AATB and its mission “to honor donors, and to save and improve lives ...
(Date:8/4/2015)... ... August 04, 2015 , ... Rhode Island Medical Imaging (RIMI) is ... Washington Medical Building on Wake Robin Road in Lincoln, RI. This satellite office ... offer the most extensive out-patient x-ray hours in the state, which includes evenings and ...
(Date:8/4/2015)... Angeles, California (PRWEB) , ... August 04, 2015 ... ... drawer slides to Los Angeles commercial customers. Finding reliable hardware can be ... unfortunate liabilities. When putting an office together or designing a new facility, ...
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, Inc. ... Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August 1, 2015. ... Dr. Carmona said. "I strongly believe in the mission of the company and ...
Breaking Medicine News(10 mins):Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3
... may be getting a little closer when robots will ... remote locations, such as on the battlefield or in ... University believe that the results of feasibility studies conducted ... achieving this space age vision of the future. Also, ...
... Successfully Tackling This Valuable ... Part of Her Job, ... -- from carpool queen to coach, counselor to chef. It,s all been,part ... inadequate nutrition, many moms have taken on yet another,important role -- that ...
... DC, May 6 , - International Reach ... AstraZeneca Support, For the first time, a ... Psychiatric Association,s (APA) prestigious "Young Minds in,Psychiatry" awards, ... Annual,Meeting in Washington, DC. The awards, supported by ...
... Market Research Reveals, CHICAGO, May 6 ... in the new three-dimensional research study --,Understanding Gluten ... international findings deliver an innovative 360 degree view,of ... qualitative,insights from customers living with food allergies, celiac ...
... CHARLOTTE, N.C., May 6 This spring graduation season,Park ... with Levine,Children,s Hospital to raise money for the Children,s ... ($27), which includes Author Anna,Quindlen,s commencement address, "A Short ... Guide to a Short Life, A Response to Ms.,Quindlen,s ...
... Opportunities at 120 Hospital-Affiliated ... ... Clarient, Inc.,(Nasdaq: CLRT ), a premier anatomic pathology and ... announced that it has signed a one-year agreement with Joint ...
Cached Medicine News:Health News:First steps toward autonomous robot surgeries 2Health News:First steps toward autonomous robot surgeries 3Health News:Got Milk? Campaign Will Recognize and Reward Moms for Their Role as the Family's Chief Health Officer 2Health News:Got Milk? Campaign Will Recognize and Reward Moms for Their Role as the Family's Chief Health Officer 3Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 2Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 3Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 4Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 5Health News:80% of Customers Eat Out Less Due to Food Allergies and Celiac / Coeliac Disease Impacting Quality of Life 2Health News:Graduation Gift Books to Benefit Levine Children's Hospital 2Health News:Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays 2Health News:Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays 3Health News:Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays 4
... special order products are offered as 1-piece ... lengths. The modular instruments may be customized ... such as ratchets, insulation and flush ports. ... stock. Customer specifications may affect delivery times. ...
... Many special order products are offered ... extra long lengths. The modular instruments may ... other options such as ratchets, insulation and ... from Mediflex stock. Customer specifications may affect ...
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
Medicine Products: